Professional Documents
Culture Documents
EYE DISEASE
To our patients
DIABETIC
EYE DISEASE
An Illustrated Guide to Diagnosis
and Management
Kritzinger, E. E.
Diabetic eye disease.
1. Diabetes-Complications and sequelae
2. Eye--Diseases and defects
I. Title II. Taylor, K. G.
616.4'62 RC660
ISBN-13: 978-94-011-6346-0 e-ISBN-13: 978-94-011-6344-6
DOl: 10.1007/978-94-011-6344-6
Introduction 7
5
4. Fundus Abnormalities Requiring
Differentiation from Diabetic Retinopathy 65
Myelinated nerve fibres 66
Choroiditis 68
Senile macular degeneration 70
5. Special Techniques Used in Ophthalmology 73
Fundus fluorescein angiography 74
Retinal photocoagulation 76
Vitrectomy 80
6. The Referral Letter 83
Conclusion 85
Index 87
6
Introduction
7
1
9
TESTING VISUAL ACUITY
Method
10
Test distant visual acuity
E .
A
•
III 3 D F"
HCU
HZP
l1IEPl TXUD
Z AO NH
fTlEfTllIJ3 OHLEN
3W3EIIIW CEATH O
III ... E 3
31£ • • • £:'111
... lid E
.
ACE H L N
TLCNOHD
" •• II ••••
11
Correct the refractive error
If the visual acuity is worse than 6/6, correct the refractive
error with the patient's spectacles for distant vision, if worn. It is
important during the test to ensure that the patient does not
confuse reading spectacles with those used for distant vision.
The pinhole test (opposite) can be used to differentiate
between impaired vision due to refractive error and that due to
pathology in the eye. The pinhole test overcomes refractive
errors and improves the visual acuity. Provided the
intervening structures are healthy it is a useful test of macular
function. Worsening of the vision during the pinhole test
suggests maculopathy in the diabetic patient and alerts to the
presence of macular oedema, haemorrhage or exudates.
Action
12
Figure 3 Pinhole cards are easy to make. Multiple pinholes
help the patient to find one quickly.
13
USING THE OPHTHALMOSCOPE
14
Which mydriatic?
15
When is a mydriatic contraindicated?
16
Fundus examination
17
THE NORMAL FUNDUS
18
The fundus should be examined methodically in the following
sequence:
Optic disc
Peripheral retina, divided into quadrants: superior nasal
and temporal, inferior nasal and temporal
Macula - this should be examined last to minimise
photophobia
19
RECORDING THE FINDINGS
IDate i
R •
- - ----
I
+-~~~-- -~--
L •
i
--~~
20
2
Diabetic retinopathy
Pseudopapilloedema
Rubeosis of the iris
Cataract
Cranial nerve palsy
21
DIABETIC RETINOPATHY
• Those patients who have had diabetes the longest are most
at risk.
• The prevalence of diabetic retinopathy is related to the age
at onset and to the duration of diabetes.
• 7 ~o of patients aged 0-19 years at diagnosis will have DR
after 10 years.
10 %of patients aged 20-39 years at diagnosis will have DR
after 10 years.
25 %of patients aged 40 + years at diagnosis will have DR
after 10 years.
All patients attending the Diabetic Clinic should have theyearof
diagnosis and their date of birth prominently displayed in the notes.
22
Q.2 Which other patients are at risk of developing
diabetic retinopathy?
23
Background Retinopathy
Action
24
Background Retinopathy
25
Background Retinopathy
Hard exudates
Action
26
Background Retinopathy
27
Diabetic Maculopathy
Macular oedema
Visual acuity will be impaired and the pinhole test (p. 12) will
make the vision worse (a useful clinical clue).
Action
28
Diabetic Maculopathy
29
Diabetic Maculopathy
Diffuse maculopathy
Action
30
Diabetic Maculopathy
31
Diabetic Maculopathy
Circinate maculopathy
Action
32
Diabetic Maculopathy
33
Pre-proliferative Diabetic Retinopathy
Action
34
Pre-proliferative Diabetic Retinopathy
35
Proliferative Diabetic Retinopathy
Action
36
Proliferative Diabetic Retinopathy
37
Proliferative Diabetic Retinopathy
Action
38
Proliferative Diabetic Retinopathy
39
Proliferative Diabetic Retinopathy
Action
40
Proliferative Diabetic Retinopathy
41
Advanced Diabetic Retinopathy
Action
42
Advanced Diabetic Retinopathy
43
PSEUDOPAPILLOEDEMA
Action
44
PSEUDOPAPILLOEDEMA
45
RUBEOSIS OF THE IRIS
Action
If new vessels are seen on the iris the patient should have early
referral to an ophthalmologist, ideally within a month.
46
RUBEOSIS OF THE IRIS
Action
48
CATARACT
49
CRANIAL NERVE PALSY
Palsy ofthe third, fourth or sixth cranial nerve may occur with
only mild diabetes. Improvement of ophthalmoplegia and
diplopia usually begins within three weeks although symptoms
may persist for up to three months. It is important to
distinguish diabetic ophthalmoplegia from that due to an
intracranial space-occupying lesion or migraine. When the
third nerve is involved the pupil is usually spared in dIabetes
but dilated in the other two conditions.
Action
50
CRANIAL NERVE PALSY
Figure 38 Third nerve palsy with ptosis affecting the left eye.
(Figures 37 and 38 courtesy Orthoptic Department,
Birmingham and Midland Eye Hospital)
51
3
53
RETINAL VEIN OCCLUSION
Action
54
RETINAL VEIN OCCLUSION
55
ASTEROID HY ALOSIS
Action
56
ASTEROID HYALOSIS
57
CUPPING OF THE OPTIC DISC (Chronic glaucoma)
Action
58
CUPPING OF THE OPTIC DISC (Chronic glaucoma)
59
LIPAEMIA RETINALIS
Action
60
LIPAEMIA RETINALIS
61
XANTHELASMATA AND CORNEAL ARCUS
Xanthelasmata may be associated with hyperlipidaemia and lor
diabetes. When hyperlipidaemia is present it is usually
hypercholesterolaemia.
Corneal arcus is commonly seen in older patients and
probably signifies underlying atherosclerosis. In patients aged
under 40 years it suggests premature atherosclerosis and an
underlying cause should be sought.
Both xanthelasmata and corneal arcus may occur in patients
without diabetes or an apparent lipid abnormality.
Action
62
XANTHELASMATA AND CORNEAL ARCUS
63
4
65
MYELINATED NERVE FIBRES
Action
66
MYELINATED NERVE FIBRES
67
CHOROIDITIS
Action
68
CHOROIDITIS
Figure 49 Choroiditis.
69
SENILE MACULAR DEGENERATION
Action
70
SENILE MACULAR DEGENERATION
71
5
73
FUNDUS FLUORESCEIN ANGIOGRAPHY
74
FUNDUS FLUORESCEIN ANGIOGRAPHY
75
RETINAL PHOTOCOAGULATION
76
RETINAL PHOTOCOAGULATION
77
Effects of Retinal Photocoagulation
Macular Exudates
78
Effects of Retinal Photocoagulation
New Vessels
79
VITRECTOMY
80
VITRECTOMY
Operating microscope
Aspiration cutter
Lens Cornea
Vitreous haemorrhage
81
6
83
Conclusion
85
Index
glaucoma 16
diabetes chronic 58-9
glycaemic control 24 neovascular 46-7, 54
types 1 and 2 23 glycaemic control 24
diabetic retinopathy 22
advanced 42-3, 80 haemorrhage
background 24-7 macular 12,31
pre-proliferative 34-5 retinal 22, 25, 36, 38-9, 55
prevalence and risk factors 22-3 vitreous and pre-retinal 22, 36,
proliferative 36-41,46,75-6 38-41,54
screening 23 hypercholesterolaemia 62
symptoms 23, 38 hyperlipidaemia 54, 62
see also maculopathy hypertension 54
diplopia 50 hypertriglyceridaemia 60-1
87
intraocular pressure photocoagulation 36, 46, 54, 69,
in chronic glaucoma 58 70, 76-9
iris, rubeosis of 46-7, 54 pinhole test 12-13, 28, 70
iritis 47 pseudopapilloedema 44-5
ischaemia see iris, retina ptosis 51
pupillary dilation
keratic precipitates 47 abnormal 50
by mydriatic 14-16, 74, 76
laser see photocoagulation
lens
intraocular 16 referral letter 83
opacities 17, 48 refractive error correction 10, 12
see also cataract retina
lipaemia retinalis 60-1 detachment 22, 42-3
ischaemia 34, 36, 54, 74-6
macula, senile degeneration of neovascularisation and haemor-
disciform scar 71 rhage 22, 36-9, 54, 76, 79
drusen 71 scarring 69
dry pigmentary change 70 see also under diabetic retino-
maculopathy, diabetic 12, 22, pathy, fundus, maculopathy
28-33 retinal vein occlusion 54-5
circinate 32-3
diffuse 30-1
Snellen's charts 11
oedema 12, 28-9
spectacles
use of photocoagulation 78
prescription of and glycaemic
visual acuity in 12, 28
control 48
microaneurysms 22, 25, 75, 76
use of in visual testing 12, 14
mydriatic 15-16, 74, 76
88